Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 871.35
+17.85 (2.09%)
At close: Sep 25, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 215.92 billion as of September 25, 2026. Its market cap has increased by 67.61% in one year.
Market Cap
215.92B
Enterprise Value
221.69B
Revenue
56.32B
Ranking
n/a
PE Ratio
32.33
Stock Price
871.35
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 215.92B, an increase of 131,798.43%. That is a compound annual growth rate of 35.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 215.92B | 48.65% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 572.37B |
| GlaxoSmithKline Pharmaceuticals | 477.19B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Caplin Point Laboratories | 215.55B |
| Jubilant Pharmova | 170.13B |
| AstraZeneca Pharma India | 162.95B |
| Viyash Scientific | 106.69B |
| Procter & Gamble Health | 89.87B |